Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations

Sook S. Wong(Howard Hughes Medical Institute), Owen N. Witte(Howard Hughes Medical Institute), Cuilin Zhang(National University of Singapore), Kevan M. Shokat(Howard Hughes Medical Institute), D. Cheng(Howard Hughes Medical Institute), J McLaughlin(Howard Hughes Medical Institute)
Proceedings of the National Academy of Sciences
October 25, 2004
10.1073/pnas.0407061101
Cited by 71

Related Papers

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k
The translational landscape of mTOR signalling steers cancer initiation and metastasis
|Nature|2012|1.4k
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
|Cell|2006|1.2k